Coagulation Monitoring Products Market Size Share and Industry Outlook to 2028

SKU: DMMD4156 | Last Updated On: Jan 20 2022 | No. of Pages: 180 | Available Formats

> Global Coagulation Monitoring Products Market Expected to reach a high CAGR By 2028: DataM Intelligence

Global Coagulation Monitoring Products Market is segmented By Product (Instruments, Assays, Reagents), By End-User (Hospitals, Clinics, and Diagnostic centers, Home Setting, Ambulatory Settings), By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2021-2028

 

Market Overview

The global coagulation monitoring products market is estimated to reach a high CAGR of 7.07% during the forecast period (2021-2028).

Coagulation tests assess blood’s ability to clot as well as the time it takes to clot. Testing can assist a doctor in determining the risk of excessive bleeding or the formation of clots (thrombosis) in blood vessels.

Source: DataM Intelligence Analysis (2021)

Market Dynamics

The factors driving the global coagulation monitoring products market are the increasing demand for point of care testing devices. In addition, increasing technological advancements in monitoring devices are also expected to drive market growth over the forecast period.

Increasing point of care testing devices is expected to drive the global coagulation monitoring products market

The rapid, specific examination of bodily fluids at the bedside is known as point-of-care testing (POCT). There is an ever-expanding range of POCT available, the majority of which are beyond the scope of this article, which will focus on those that are routinely used and important to the management of perioperative coagulation. Because typical laboratory tests have a somewhat long turnaround time. There is growing interest in point-of-care coagulation testing (POCCT) to avoid unnecessary transfusion, which can offer results in minutes. Furthermore, the widespread acceptance of the current cell-based coagulation model has resulted in a focus on the critical role of platelets and a particular interest in devices that test whole blood rather than plasma, which is employed in laboratory-based tests. The prothrombin time (PT) and activated partial thromboplastin time (aPTT), which provide information on the first phase of coagulation up to fibrin production, are examples of the latter. Viscoelastic POCCT devices, on the other hand, produce information on all phases of coagulation, offering insight into interactions between the cellular and plasma components of whole blood and the fibrinolytic system's activity which are critical for successful hemostasis.

The most recent POC coagulation analyzers produce real-time results while maintaining the central lab's diagnostic quality controls. POC testing must strike a compromise between the desire for quick findings and the absolute requirement for accuracy and QC that the lab guarantees. Siemens Healthineers' Xprecia Stride Coagulation Analyzer is a recent FDA-cleared POC PT/INR gadget. This device has established performance parity in PT/INR testing with the Roche CoaguChek XS POC system and reference laboratory analysis. Recent point-of-care PT/INR systems include both electronic and internal QC checks on test strips. Convenient device test strip ejects mechanisms allow for the safe disposal of spent strips, reducing odours.

Technological advancements in monitoring devices are expected to drive the market growth during the forecast period

Blood coagulation monitoring has been increasingly important in diagnosing the causes of hemorrhages, creating anticoagulant medications, measuring bleeding risk in prolonged surgery procedures and dialysis, and researching the efficacy of hemostatic therapy in recent years. Microfluidics, fluorescence microscopy, electrochemical sensing, photoacoustic detection, and micro/nanoelectromechanical systems (MEMS/NEMS) have been used to build extremely precise, resilient, and cost-effective points of care (POC) devices. These instruments measure the electrochemical, optical, and mechanical properties of clotting blood.

With advancements in artificial intelligence (AI) and machine learning, algorithms that can track multiple parameters concurrently throughout a treatment/diagnosis and identify patient-specific patterns that can aid in pinpointing proper treatment or underlying causes will be one of the most significant developments in coagulation measurement technologies in the coming years. With the challenges posed by novel anticoagulant technologies for current measurement techniques and the validity and applicability of diagnostic parameters such as INR, simultaneous observation of multiple parameters or complex patterns within them may be required for proper observation of patients with special needs. AI and machine learning-based algorithms may very well find a role in future new POC blood coagulation testing systems for these unique circumstances in the next years.

For instance, on June 14th 2018, Roche launched the CoaguChek Vantus system, the first self-testing coagulation monitoring gadget with Bluetooth technology. Patient self-testing using the Bluetooth-enabled CoaguChek Vantus system opened new possibilities for patient monitoring.

High cost and limitations of testing devices are expected to hamper the market growth

The major reason restricting the use of medical devices such as POC coagulation monitoring devices is the high cost of these devices compared to the laboratory tests for monitoring. Due to limited economic opportunities, low and middle-income countries (LIC/MICs) face significant challenges. In addition to economic difficulties, LICs bear a large burden of infectious diseases, posing serious risks to the population's well-being. Healthcare systems and practitioners in LICs are sometimes ill-equipped to serve patients as effectively as possible, particularly in rural areas. Given the economic and infrastructure challenges in LIC, point-of-care diagnostics, which are often distinguished by being independent of laboratory or medical infrastructure and being highly affordable and holding significant promise to improve the situation, are becoming increasingly popular.

POCT limitations include improper handling and/or maintenance of the analyzers by untrained clinical staff, insufficient or even absent calibrations and/or quality controls, a lack of cost-effectiveness due to an increased number of analyzers and more expensive reagents, insufficient documentation, and difficult comparability of the obtained POCT-results with routine laboratory results.

 Market Industry Analysis

Supply Chain Analysis:

Porter's Five Forces Analysis:

Source: DataM Intelligence Analysis (2021)

COVID-19 Impact Analysis

COVID-19 has affected the healthcare industry moderately. To stop its spread, government-imposed lockdown. People are fearful they may experience occupational effects and negative health from the COVID-19 pandemic. Because hypercoagulability has been observed in COVID-19 patients, the FDA recognized the importance and utility of increasing the availability of devices to test for and manage coagulopathies in patients in hospitals and other healthcare facilities experiencing an increase in patient load as a result of the COVID-19 public health emergency. Hence, the US Food and Drug Administration (FDA) authorizes manufacturers to adapt coagulation systems to assess whole blood viscoelastic characteristics, allowing for increased use in hospitals for supportive care of COVID-19 patients. This has boosted the global coagulation monitoring products market.

Market Segment Analysis

Based on product, viscoelastic coagulation monitor is expected to dominate the global coagulation monitoring products market

In general, viscoelastic testing refers to several commercially accessible point-of-care assays that employ a sample of patient blood to determine various characteristics relevant to the quality of the clot formed. The viscoelastic coagulation monitor (VCM) System is a revolutionary technology that leverages glass surface activation of untreated whole blood. It is a compact, portable instrument that may do a viscoelastic examination of the coagulation-fibrinolysis process at the patient's bedside. The rapid beginning of clotting is due to the large surface contact area between the extracted blood and the glass inside the cartridge. As a result, activating factors are not required. The VCM was recently compared to the ROTEM NATEM (nonactivated method). The results showed good-to-moderate agreement in test results between the two systems in a cohort of patients undergoing major surgery.

On January 19th 2021, HemoSonics, according to the US Food and Drug Administration (FDA) guidelines issued on January 14th broadened the usage of viscoelastic coagulation analyzers in-hospital patient healthcare settings in response to COVID-19. The FDA guidance is intended to increase the availability of coagulation systems for measuring whole blood viscoelastic properties to assess hemostasis during the COVID-19 public health emergency.

Geographical Analysis

North America region accounted for the largest market share in the global coagulation monitoring products market

With the growing incidence of bleeding disorders and increasing approvals, this region is expected to dominate the global coagulation monitoring products market.

In the United States, one in every 5,000 male births is affected by hemophilia A, and around 400 babies are born with hemophilia each year. Haemophilia affects 400 thousand people worldwide, with around 20,000 affected in the United States. According to CDC, the exact number of hemophilia patients in the United States is unknown. According to a new study that analysed data collected on patients receiving care in federally sponsored hemophilia treatment centres from 2012 to 2018, up to 33,000 boys in the United States have the illness. As of 2019, 18,008 persons were diagnosed with haemophilia, a genetic blood condition that impairs normal blood clotting and coagulation.

The US Food and Drug Administration (FDA) authorised manufacturers to adapt coagulation systems for assessing whole blood viscoelastic characteristics, allowing for increased use in hospitals for supportive care of COVID-19 patients. The enforcement policy, published in January 2021, is only temporary and will be in effect only during the COVID-19 public health emergency.

Source: DataM Intelligence Analysis (2021)

Competitive Landscape

The global coagulation monitoring products market is highly competitive with the increasing demand during COVID-19 and technological advancement in products.

Major key players in the global coagulation monitoring products market are CoaguSense Inc., Helena Laboratories, Hemosonics, Siemens, Thermo Fisher Scientific, HORIBA Medical, Maccura Biotechnology Co., Sclavo Diagnostics International S.r.l, Biosystems S. and Bio Group Medical System.

Siemens Healthineers

Overview: Siemens Healthineers AG is the market leader in diagnostic imaging. The company is in Erlangen, Germany. It is the parent company of various medical technology companies. The company’s diagnostic imaging equipment include computed tomography, magnetic resonance imaging, molecular imaging, X-ray products, ultrasound systems, and imaging IT.

Product Portfolio: Siemens Healthineers hemostasis products include Sysmex CN-3000 and CN-6000 Systems, Atellica COAG 360 System1 is a fully automated high-volume coagulation analyzer and Hemostasis Assays

Why Purchase the Report?

  • Visualize the composition of the global coagulation monitoring products market segmentation by product and end-user highlighting the key commercial assets and players.
  • Identify commercial opportunities in the global coagulation monitoring products market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global coagulation monitoring products market-level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global coagulation monitoring products market report would provide access to an approx. 45+market data table, 40+figures and 180 pages.  

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Coagulation Monitoring Products Market - By Product

  • Instruments
    • Viscoelastic Coagulation Monitor
    • Anticoagulation Monitors
    • Platelet Functioning Monitoring Devices
    • Haemostasis Analyzer
  • Assays
    • Anti-Xa assay
    • Heparin Assay
    • Dimer Assay
  • Reagents
    • Thromboplastin liquid
    • Thrombospan LS
    • Thrombospan LS aPTT-EA

Global Coagulation Monitoring Products Market - By End-User

  • Hospitals
  • Clinics and Diagnostic centers
  • Home Setting
  • Ambulatory Settings

Global Coagulation Monitoring Products Market - By Region

  • North America
  • Europe
  • South America
  • Asia Pacific
  • Middle East and Africa

Trending Topics

Cardiometabolic Monitoring Products Market

Patient Fluid Status Monitor Device Market

 

Table of Contents

  1. Global Coagulation Monitoring Products Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Global Coagulation Monitoring Products Market – Market Definition and Overview

  3. Global Coagulation Monitoring Products Market – Executive Summary

    1. Market Snippet By Product
    2. Market Snippet By End-User
    3. Market Snippet By Region
  4. Global Coagulation Monitoring Products Market -Market Dynamics

    1. Market Impacting Factors
      1. Drivers
        1. Increasing point of care testing devices
        2. Technological advancements in the monitoring devices
      2. Restraints:
        1. High cost and limitations of testing devices
      3. Opportunity
      4. Impact Analysis
  5. Global Coagulation Monitoring Products Market – Industry Analysis

    1. Porter's Five Forces Analysis
    2. Supply Chain Analysis
    3. Pricing Analysis
    4. Regulatory Analysis
    5. Reimbursement Analysis
    6. Unmet Needs
  6. Global Coagulation Monitoring Products Market – COVID-19 Analysis

    1. Analysis of Covid-19 on the Market
      1. Before COVID-19 Market Scenario
      2. Present COVID-19 Market Scenario
      3. After COVID-19 or Future Scenario
    2. Pricing Dynamics Amid Covid-19
    3. Demand-Supply Spectrum
    4. Government Initiatives Related to the Market During Pandemic
    5. Manufacturers Strategic Initiatives
    6. Conclusion 
  7. Global Coagulation Monitoring Products Market – By Product 

    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    3. Market Attractiveness Index, By Product
      1. Instruments
        1. Viscoelastic Coagulation Monitor*
          1. Introduction
          2. Market Size Analysis, US$ Mn, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
        2. Anticoagulation Monitors
        3. Platelet Functioning Monitoring Devices
        4. Haemostasis Analyzer
      2. Assays 
        1. Anti-Xa assay
          1. Introduction
          2. Market Size Analysis, US$ Mn, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
        2. Heparin Assay
        3. Dimer Assay
      3. Reagents 
        1. Thromboplastin liquid
          1. Introduction
          2. Market Size Analysis, US$ Mn, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
        2. Thrombospan LS
        3. Thrombospan LS aPTT-EA
  8. Global Coagulation Monitoring Products Market – By End-User

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
      2. Market Attractiveness Index, By End-User Segment
    2. Hospitals*
      1. Introduction
      2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    3. Clinics and Diagnostic centers
    4.  Home Setting
    5.  Ambulatory Settings
  9. Global Coagulation Monitoring Products Market – By Region

    1. Introduction
      1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. U.S.
        2. Canada
        3. Mexico
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    5. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    6. Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  10. Global Coagulation Monitoring Products Market – Competitive Landscape

    1. Key Developments and Strategies
    2. Company Share Analysis
    3. Product Benchmarking
  11. Global Coagulation Monitoring Products Market - Company Profiles

    1. Siemens Healthineers*
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. CoaguSense Inc.
    3. Helena Laboratories
    4. Hemosonics
    5. Thermo Fisher Scientific
    6. HORIBA Medical
    7. Maccura Biotechnology Co.
    8. Sclavo Diagnostics International S.r.l
    9. Biosystems S.A.
    10. Bio Group Medical System(*LIST NOT EXHAUSTIVE)
  12. Global Coagulation Monitoring Products Market – DataM   

    1.       Appendix
    2. About Us and Services
    3. Contact Us

 

List of Tables & Figures

List of Tables

Table 01  Global Coagulation Monitoring Products Market Value, By Product, 2020, 2024 & 2028 ($ Million)

Table 02 Global Coagulation Monitoring Products Market Value, By End-User, 2020, 2024 & 2028 ($ Million)

Table 03 Global Coagulation Monitoring Products Market Value, By Region, 2020, 2024 & 2028 ($ Million)

Table 04  Global Coagulation Monitoring Products Market Value, By Product, 2020, 2024 & 2028 ($ Million)

Table 05  Global Coagulation Monitoring Products Market Value, By Product, 2019-2028 ($ Million)

Table 06  Global Coagulation Monitoring Products Market Value, By End-User, 2020, 2024 & 2028 ($ Million)

Table 07  Global Coagulation Monitoring Products Market Value, By End-User, 2019-2028 ($ Million)

Table 08  Global Coagulation Monitoring Products Market Value, By Region, 2020, 2024 & 2028 ($ Million)

Table 09  Global Coagulation Monitoring Products Market Value, By Region, 2019-2028 ($ Million)

Table 10 North America Coagulation Monitoring Products Market Value, By Product, 2019-2028 ($ Million)

Table 11 North America Coagulation Monitoring Products Market Value, By End-User, 2019-2028 ($ Million)

Table 12 North America Coagulation Monitoring Products Market Value, By Country, 2019-2028 ($ Million)

Table 13 South America Coagulation Monitoring Products Market Value, By Product, 2019-2028 ($ Million)

Table 14 South America Coagulation Monitoring Products Market Value, By End-User, 2019-2028 ($ Million)

Table 15 South America Coagulation Monitoring Products Market Value, By Country, 2019-2028 ($ Million)

Table 16 Europe Coagulation Monitoring Products Market Value, By Product, 2019-2028 ($ Million)

Table 17 Europe Coagulation Monitoring Products Market Value, By End-User, 2019-2028 ($ Million)

Table 18 Europe Coagulation Monitoring Products Market Value, By Country, 2019-2028 ($ Million)

Table 19 Asia-Pacific Coagulation Monitoring Products Market Value, By Product, 2019-2028 ($ Million)

Table 20 Asia-Pacific Coagulation Monitoring Products Market Value, By End-User, 2019-2028 ($ Million)

Table 21 Asia-Pacific Coagulation Monitoring Products Market Value, By Country, 2019-2028 ($ Million)

Table 22 Middle East & Africa Coagulation Monitoring Products Market Value, By Product, 2019-2028 ($ Million)

Table 23 Middle East & Africa Coagulation Monitoring Products Market Value, By End-User, 2019-2028 ($ Million)

Table 24 Siemens Healthineers: Overview

Table 25 Siemens Healthineers: Product Portfolio

Table 26 Siemens Healthineers: Key Developments

Table 27 CoaguSense Inc.: Overview

Table 28 CoaguSense Inc.: Product Portfolio

Table 29 CoaguSense Inc.: Key Developments

Table 30 Helena Laboratories: Overview

Table 31 Helena Laboratories: Product Portfolio

Table 32 Helena Laboratories: Key Developments

Table 33 Hemosonics: Overview

Table 34 Hemosonics: Product Portfolio

Table 35 Hemosonics: Key Developments

Table 36 Thermo Fisher Scientific: Overview

Table 37 Thermo Fisher Scientific: Product Portfolio

Table 38 Thermo Fisher Scientific: Key Developments

Table 39  HORIBA Medical: Overview

Table 40  HORIBA Medical: Product Portfolio

Table 41  HORIBA Medical: Key Developments

Table 42  Maccura Biotechnology Co.: Overview

Table 43  Maccura Biotechnology Co.: Product Portfolio

Table 44  Maccura Biotechnology Co.: Key Developments

Table 45 Sclavo Diagnostics International S.r.l: Overview

Table 46 Sclavo Diagnostics International S.r.l: Product Portfolio

Table 47 Sclavo Diagnostics International S.r.l: Key Developments

Table 48  Biosystems S.A.: Overview

Table 49  Biosystems S.A.: Product Portfolio

Table 50  Biosystems S.A.: Key Developments

Table 51  Bio Group Medical System: Overview

Table 52  Bio Group Medical System: Product Portfolio

Table 53  Bio Group Medical System: Key Developments

List of Figures

Figure 01 Global Coagulation Monitoring Products Market Share, By Product, 2020 & 2028 (%)

Figure 02 Global Coagulation Monitoring Products Market Share, By End-User, 2020 & 2028 (%)

Figure 03 Global Coagulation Monitoring Products Market Share, By Region, 2020 & 2028 (%)

Figure 04 Global Coagulation Monitoring Products Market Value, 2019-2028 ($ Million)

Figure 05 Global Coagulation Monitoring Products Market Y-o-Y Growth, By Product, 2020-2028 (%)

Figure 06 Instruments Devices: Global Coagulation Monitoring Products Market Value, 2019-2028 ($ Million)

Figure 07 Assays: Global Coagulation Monitoring Products Market Value, 2019-2028 ($ Million)

Figure 08 Reagents: Global Coagulation Monitoring Products Market Value, 2019-2028 ($ Million)

Figure 09 Global Coagulation Monitoring Products Market Y-o-Y Growth, By End-User, 2020-2028 (%)

Figure 10 Hospitals: Global Coagulation Monitoring Products Market Value, 2019-2028 ($ Million)

Figure 11 Clinics and Diagnostic Centers: Global Coagulation Monitoring Products Market Value, 2019-2028 ($ Million)

Figure 12 Home Setting: Global Coagulation Monitoring Products Market Value, 2019-2028 ($ Million)

Figure 13 Ambulatory Settings: Global Coagulation Monitoring Products Market Value, 2019-2028 ($ Million)

Figure 14 Global Coagulation Monitoring Products Market Y-o-Y Growth, By Region, 2020-2028 (%)

Figure 15 North America Coagulation Monitoring Products Market Value, 2019-2028 ($ Million)

Figure 16 North America Coagulation Monitoring Products Market Share, By Product, 2020 & 2028 (%)

Figure 17 North America Coagulation Monitoring Products Market Share, By End-User, 2020 & 2028 (%)

Figure 18 North America Coagulation Monitoring Products Market Share, By Country, 2020 & 2028 (%)

Figure 19 South America Coagulation Monitoring Products Market Share, 2019-2028 ($ Million)

Figure 20 South America Coagulation Monitoring Products Market Share, By Product, 2020 & 2028 (%)

Figure 21 South America Coagulation Monitoring Products Market Share, By End-User, 2020 & 2028 (%)

Figure 22 South America Coagulation Monitoring Products Market Share, By Country, 2020 & 2028 (%)

Figure 23 Europe Coagulation Monitoring Products Market Value, 2019-2028 ($ Million)

Figure 24 Europe Coagulation Monitoring Products Market Share, By Product, 2020 & 2028 (%)

Figure 25 Europe Coagulation Monitoring Products Market Share, By End-User, 2020 & 2028 (%)

Figure 26 Europe Coagulation Monitoring Products Market Share, By Country, 2020 & 2028 (%)

Figure 27 Asia-Pacific Coagulation Monitoring Products Market Value, 2019-2028 ($ Million)

Figure 28 Asia-Pacific Coagulation Monitoring Products Market Share, By Product, 2020 & 2028 (%)

Figure 29 Asia-Pacific Coagulation Monitoring Products Market Share, By End-User, 2020 & 2028 (%)

Figure 30 Asia-Pacific Coagulation Monitoring Products Market Share, By Country, 2020 & 2028 (%)

Figure 31 Middle East & Africa Coagulation Monitoring Products Market Value, 2019-2028 ($ Million)

Figure 32 Middle East & Africa Coagulation Monitoring Products Market Share, By Product, 2020 & 2028 (%)

Figure 33 Middle East & Africa Coagulation Monitoring Products Market Share, By End-User, 2020 & 2028 (%)

Figure 34 Siemens Healthineers: Financials

Figure 35 CoaguSense Inc.: Financials

Figure 36 Helena Laboratories: Financials

Figure 37 Hemosonics: Financials

Figure 38 Thermo Fisher Scientific: Financials

Figure 39  HORIBA Medical: Financials

Figure 40  Maccura Biotechnology Co.: Financials

Figure 41 Sclavo Diagnostics International S.r.l: Financials

Figure 42  Biosystems S.A.: Financials

Figure 43  Bio Group Medical System: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*



Year-End Offer from
DataM Intelligence

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest